The PTCB exam changed in January 2026. Learn the current PTCE domains, updated percentages, new Federal Requirements content, topics that were removed, and exactly where to focus your study time.
Quick Answer
Yes—the PTCB Pharmacy Technician Certification Exam (PTCE) changed in 2026.
The current PTCE Content Outline took effect on January 6, 2026, and candidates preparing now should make sure their study materials follow this version rather than the older 2020 blueprint.
The current exam is divided into four domains:
| PTCE Domain | Current Exam Weight |
|---|---|
| Medications | 35% |
| Federal Requirements | 18.75% |
| Patient Safety and Quality Assurance | 23.75% |
| Order Entry and Processing | 22.50% |
The biggest shift is Federal Requirements, which increased from 12.5% under the previous outline to 18.75% now. The older exam devoted 40% to Medications, 26.25% to Patient Safety and Quality Assurance, and 21.25% to Order Entry and Processing.
The updated exam also specifically includes Drug Supply Chain Security Act (DSCSA) requirements, including serialization, product tracking and tracing, handling, and quarantine requirements.
If your PTCB study guide still tells you that Federal Requirements make up 12.5% of the exam, it is preparing you from the old blueprint.
What Is the PTCB Exam?
The Pharmacy Technician Certification Exam, or PTCE, is the certification examination administered by the Pharmacy Technician Certification Board (PTCB) for candidates seeking the Certified Pharmacy Technician (CPhT) credential.
The current PTCE contains:
- 90 multiple-choice questions
- 80 scored questions
- 10 unscored questions
- Four answer choices per question
- 1 hour and 50 minutes of actual exam time
- A total testing appointment of approximately 2 hours
The 10 unscored questions are mixed throughout the test and are not identified, so you should treat every question as though it counts.
The passing scaled score remains 1,400, with possible PTCE scores ranging from 1,000 to 1,600.
The Current PTCB Exam Breakdown
Understanding the percentages matters because it tells you where your study time has the greatest potential return.
Domain 1: Medications — 35%
Medications remains the largest section of the PTCE.
The current PTCB outline tests:
- Generic names
- Brand names
- Drug classifications
- Therapeutic duplications
- Drug interactions
- Contraindications
- Strengths and doses
- Dosage forms
- Routes of administration
- Special handling
- Duration of therapy
- Common and severe side effects
- Adverse effects
- Allergies
- Medication indications
- Drug stability
- Medication storage
This means memorizing brand and generic names is important—but it is not enough.
What You Actually Need to Know About Drugs
For high-frequency medications, train yourself to answer several questions about each drug.
For example:
Lisinopril
Can you identify:
- Brand name?
- Drug class?
- Common indication?
- Important adverse effect?
- Important contraindication or interaction?
- Dosage form?
That is closer to the level of understanding required than simply knowing:
Prinivil = lisinopril.
Study Drugs by Class, Not as 200 Random Facts
One of the most efficient PTCB strategies is learning medication families.
For example:
ACE Inhibitors
Common clue:
-pril
Examples:
- Lisinopril
- Enalapril
- Ramipril
Angiotensin II Receptor Blockers
Common clue:
-sartan
Examples:
- Losartan
- Valsartan
Beta Blockers
Many end in:
-olol
Examples:
- Metoprolol
- Atenolol
- Propranolol
Statins
Common clue:
-statin
Examples:
- Atorvastatin
- Rosuvastatin
- Simvastatin
Proton Pump Inhibitors
Many end in:
-prazole
Examples:
- Omeprazole
- Pantoprazole
- Lansoprazole
Suffixes are useful shortcuts—but never assume a drug belongs to a class based only on its ending. Exceptions exist.
Therapeutic Duplication
Therapeutic duplication appears explicitly in the current Medications domain.
Therapeutic duplication occurs when a patient receives two medications with similar therapeutic effects when that combination may not be intentional.
Example
A patient’s profile contains two drugs from the same therapeutic class.
The pharmacy technician should not independently decide that one should be discontinued.
Instead, recognize the issue and bring it to the pharmacist’s attention.
PTCB Principle
The exam often tests:
Can you recognize when pharmacist intervention is required?
It does not expect the technician to independently make clinical treatment decisions.
Drug Interactions and Contraindications
The current blueprint specifically tests common or life-threatening:
- Drug-drug interactions
- Drug-supplement interactions
- Drug-laboratory interactions
- Drug-food or nutrient interactions
- Drug-disease contraindications
This is why studying medications only through brand/generic flashcards leaves a major gap.
You should recognize important patterns such as:
- Drugs that increase bleeding risk
- CNS depressants used together
- Important food-drug interactions
- Drugs that should be avoided with certain medical conditions
- Combinations requiring pharmacist review
Drug Stability Is Still Testable
Drug stability remains explicitly included in the current PTCE blueprint.
Examples listed by PTCB include:
- Oral suspensions
- Insulins
- Reconstituted medications
- Injectable medications
- Vaccinations
Students should understand that stability can depend on:
- Time after opening or reconstitution
- Storage temperature
- Exposure to light
- Product-specific instructions
Do not assume every medication simply remains usable until the manufacturer’s printed expiration date after it has been opened or reconstituted.
Domain 2: Federal Requirements — 18.75%
This is one of the most important changes to the current PTCE.
Under the older outline, Federal Requirements represented 12.5% of exam content.
It now represents 18.75%.
That is a substantial increase.
Candidates using old study plans may therefore be understudying federal law.
What Federal Requirements Now Covers
The current blueprint includes:
- Handling and disposal of pharmaceutical substances and waste
- Hazardous substances
- Controlled-substance prescriptions
- DEA controlled-substance schedules
- Receiving controlled substances
- Storage
- Ordering
- Labeling
- Dispensing
- Returns
- Drug take-back programs
- Loss or theft
- Destruction of controlled substances
- Restricted drug programs
- Pseudoephedrine requirements
- REMS
- FDA medication recalls
- DSCSA requirements
Controlled Substance Schedules
You should know the practical differences between Schedule I through Schedule V.
Schedule I
Federal law classifies Schedule I substances as having no currently accepted medical use in treatment in the United States and a high potential for abuse.
These are not routine prescription medications dispensed by a retail pharmacy.
Schedule II
Schedule II medications have accepted medical uses but high abuse potential.
A critical PTCB rule:
Schedule II prescriptions cannot be refilled.
Examples candidates commonly study include medications containing:
- Oxycodone
- Fentanyl
- Morphine
- Amphetamine
Schedule III and IV
Federal prescription rules allow up to five refills within six months for Schedule III and IV controlled substances.
This is one of the classic PTCE distinctions.
Schedule V
Schedule V contains controlled substances with lower abuse potential relative to the higher schedules.
The exact dispensing rules can depend on the medication and applicable federal and state law.
PTCB Controlled-Substance Shortcut
Remember:
C-II = no refills.
C-III and C-IV = up to 5 refills in 6 months under federal law.
Then study the additional prescription, transfer, ordering, storage, and recordkeeping requirements separately.
DSCSA: A Major Current Topic
One of the most important current additions is the Drug Supply Chain Security Act (DSCSA).
The current PTCB outline specifically tests FDA requirements for:
- Product serialization
- Tracking
- Tracing
- Handling
- Quarantining drug products
If your PTCB course barely mentions DSCSA, it may have been built for the old exam.
What Is the DSCSA?
The Drug Supply Chain Security Act created requirements designed to improve the ability to identify and trace certain prescription drugs as they move through the U.S. pharmaceutical supply chain.
For PTCE purposes, focus on the pharmacy technician’s role in recognizing and appropriately handling products that may be:
- Suspect
- Illegitimate
- Damaged
- Improperly documented
- Subject to investigation or quarantine
You do not need to become a pharmaceutical-distribution attorney.
You need to understand what the pharmacy should do when the integrity or legitimacy of a product is questionable.
Quarantine Means Don’t Dispense It
A very useful exam principle:
If a drug product is identified as suspect and requires investigation, it should not simply remain mixed with normal dispensable inventory.
The product may need to be:
- Separated
- Quarantined
- Investigated
- Documented
- Escalated according to procedure
Exam Trap
A technician discovers a suspicious pharmaceutical package with questionable product information.
The correct action is not:
“Dispense it because the medication inside looks normal.”
Product integrity and supply-chain verification matter.
Drug Recalls
FDA medication recalls remain part of the current Federal Requirements domain.
Candidates should understand the general severity structure.
Class I Recall
The most serious classification.
There is a reasonable probability that use or exposure could cause serious adverse health consequences or death.
Class II Recall
Use or exposure may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.
Class III Recall
Use or exposure is not likely to cause adverse health consequences.
Memory Shortcut
Class I = highest health risk.
Do not mistakenly assume that a larger class number means a more dangerous recall.
Domain 3: Patient Safety and Quality Assurance — 23.75%
Patient Safety and Quality Assurance now represents 23.75% of PTCE content.
The current outline includes:
- High-alert medications
- Look-alike/sound-alike medications
- Error-prevention strategies
- Tall Man lettering
- Inventory separation
- Leading and trailing zero rules
- Bar-code use
- Error-prone abbreviations
- Situations requiring pharmacist intervention
- Medication-error reporting
- MedWatch
- VAERS
- Near misses
- Root-cause analysis
- Continuous quality improvement
- Prescription errors
- Infection-prevention procedures
Look-Alike/Sound-Alike Drugs
LASA medications are medications whose names or appearance can be easily confused.
Examples of potentially confusing names can include medications with similar spelling or pronunciation.
The important PTCE concept is error prevention.
Strategies include:
- Tall Man lettering
- Separating inventory
- Barcode verification
- Careful selection during data entry
- Pharmacist intervention when needed
Tall Man Lettering
Tall Man lettering uses uppercase letters to emphasize differences between confusing drug names.
The goal is to reduce selection and dispensing errors.
PTCB specifically identifies Tall Man lettering as an error-prevention strategy in the current outline.
Leading and Trailing Zeros
This is a classic patient-safety test point.
Correct:
0.5 mg
Dangerous:
.5 mg
Why?
The decimal point may be missed, making .5 appear to be 5 mg.
Correct:
5 mg
Dangerous:
5.0 mg
Why?
The decimal may be missed, making 5.0 appear to be 50 mg.
Remember:
Use a leading zero.
Never use an unnecessary trailing zero.
When Must the Pharmacist Intervene?
The updated outline specifically includes situations requiring pharmacist intervention, including:
- Drug utilization review
- Adverse drug events
- OTC recommendations
- Therapeutic substitution
- Medication misuse
- Adherence issues
- Post-immunization care
- Allergies
- Drug interactions
This leads to one of the most useful PTCB decision rules:
If the situation requires clinical judgment, the pharmacist should be involved.
Example
A customer asks:
“Which cough medicine is safest with my blood-pressure medications?”
Should the technician recommend one?
No.
That requires clinical assessment.
Refer the patient to the pharmacist.
MedWatch vs. VAERS
Students frequently confuse these reporting systems.
MedWatch
FDA’s safety-information and adverse-event reporting program for medications, medical devices, and other regulated products.
VAERS
Vaccine Adverse Event Reporting System.
Think:
Vaccine reaction → VAERS
Broader FDA medication/product adverse-event reporting → MedWatch
Both are specifically referenced in the current patient-safety outline.
Near Miss
A near miss is an error that is identified before it reaches the patient.
Example:
The wrong strength is selected during filling, but it is discovered during final verification before dispensing.
No patient was harmed.
But the event still provides valuable information.
A strong pharmacy safety culture asks:
Why did the error almost happen, and how can the system prevent it next time?
Root-Cause Analysis
Root-cause analysis examines why an error occurred rather than simply identifying who made it.
For example, repeated wrong-drug selections may involve:
- Similar packaging
- Adjacent storage locations
- Similar names
- Poor software design
- Workflow interruptions
The goal is preventing recurrence.
Domain 4: Order Entry and Processing — 22.50%
Order Entry and Processing now accounts for 22.50% of the PTCE.
The current outline includes:
- Formulas
- Pharmacy calculations
- Ratios
- Proportions
- Conversions
- Sig codes
- Roman numerals
- Abbreviations
- Medical terminology
- Days supply
- Quantity
- Dose
- Concentration
- Dilutions
- Administration equipment
- Lot numbers
- Expiration dates
- NDC numbers
- Returns
- Reverse distribution
Pharmacy Math Is Still Essential
Calculations are not listed as their own separate exam domain.
That does not mean pharmacy math is unimportant.
PTCB marks several current knowledge areas as containing calculation-based knowledge, including portions of Medications, Federal Requirements, Patient Safety, and Order Entry and Processing.
You should be comfortable with:
- Days supply
- Dose calculations
- Quantity calculations
- Concentrations
- Dilutions
- Ratios and proportions
- Unit conversions
Days Supply
One of the most practical pharmacy calculations is:
Days Supply = Quantity Dispensed ÷ Quantity Used Per Day
Example
Prescription:
Take 1 tablet twice daily.
Quantity dispensed:
60 tablets
Daily use:
2 tablets
60 ÷ 2 = 30 days
Liquid Days Supply
Prescription:
Take 10 mL twice daily.
Bottle contains:
300 mL
Daily use:
10 × 2 = 20 mL
300 ÷ 20 = 15 days
Know Common Conversions
High-yield conversions include:
1 kg = 1,000 g
1 g = 1,000 mg
1 mg = 1,000 mcg
1 L = 1,000 mL
And for weight-based calculations:
kg = lb ÷ 2.2
Sig Codes
You should recognize common prescription abbreviations.
Examples:
| Sig | Meaning |
|---|---|
| qd | daily |
| bid | twice daily |
| tid | three times daily |
| qid | four times daily |
| prn | as needed |
| po | by mouth |
| hs | at bedtime |
But the exam also expects you to recognize error-prone abbreviations and patient-safety concerns—not simply decode a list.
NDC Numbers
The National Drug Code identifies drug products.
PTCB explicitly includes NDC numbers, lot numbers, and expiration dates in the current Order Entry and Processing domain.
Be prepared to use product identifiers to distinguish:
- Manufacturer or labeler
- Product
- Package configuration
The practical exam skill is recognizing whether the selected stock bottle matches the prescribed product.
What Was Removed or Reduced From the Old PTCE Blueprint?
This is especially important if you’re studying with materials created before 2026.
The older PTCE outline included topics that do not appear as dedicated knowledge areas in the current outline, including:
- Narrow therapeutic index medications as a standalone content point
- Physical and chemical incompatibilities related to nonsterile compounding
- Procedures for compounding nonsterile products
- Alligation calculations
The old outline also used therapeutic equivalence, while the current Medications outline specifically lists therapeutic duplications.
That does not mean every concept related to removed terminology can never appear indirectly in pharmacy practice.
It means you should allocate your study time according to the current official outline, not an outdated prep book.
The Biggest PTCB Study Mistake in 2026
Using an old study guide without realizing the exam changed.
Here is a quick check.
If your material says:
Medications: 40%
It is using the old weighting.
Federal Requirements: 12.5%
Old weighting.
Patient Safety: 26.25%
Old weighting.
Order Entry: 21.25%
Old weighting.
The current percentages are:
35% / 18.75% / 23.75% / 22.50%.
How Should You Divide Your PTCB Study Time?
You should not literally study exactly 35% of your hours on medications because your personal weaknesses matter.
But the blueprint gives you an excellent starting point.
Priority 1: Medications
Master:
- Brand/generic
- Classes
- Indications
- Major adverse effects
- Interactions
- Contraindications
- Stability
- Storage
This remains the largest domain.
Priority 2: Patient Safety
Know how to:
- Recognize errors
- Prevent errors
- Identify LASA medications
- Use safe notation
- Recognize pharmacist-intervention situations
- Understand reporting systems
- Distinguish near misses from errors that reach patients
Priority 3: Order Entry and Pharmacy Math
Do not postpone math until the night before your exam.
Practice until you can recognize the setup quickly.
Most students do not fail a math question because multiplication is difficult.
They fail because they choose the wrong setup.
Priority 4: Federal Requirements
This should receive more study time than old PTCB guides recommend.
Particularly focus on:
- Controlled substances
- DEA schedules
- Prescription/refill requirements
- Restricted products
- REMS
- Recalls
- Controlled-substance handling
- DSCSA
Federal Requirements now accounts for almost one-fifth of the exam.
What Should You Memorize vs. Understand?
Memorize
Some facts genuinely need rapid recall:
- Brand/generic pairs
- Drug classes
- Common suffixes
- Controlled-substance schedules
- Major refill rules
- Common conversions
- Sig codes
- Recall classifications
- Reporting-system names
Understand
Other questions require reasoning:
- Does this require pharmacist intervention?
- Is this a therapeutic duplication?
- Which medication error occurred?
- Is this product safe to dispense?
- Should a suspicious product be quarantined?
- Which calculation setup is appropriate?
- Which action best protects the patient?
Strong PTCE preparation needs both.
Common PTCB Exam Traps
Trap 1: Studying Only the Top 200 Drugs
Medication knowledge is essential, but it represents 35%, not the entire exam.
You still need Federal Requirements, Patient Safety, Order Entry, and calculations.
Trap 2: Using the Old Domain Percentages
The exam changed in January 2026.
Make sure your material reflects the new blueprint.
Trap 3: Ignoring DSCSA
It is explicitly included in the current Federal Requirements domain.
Trap 4: Thinking Pharmacy Technicians Make Clinical Decisions
When a situation requires clinical judgment, therapeutic recommendations, or interpretation beyond the technician’s role, involve the pharmacist.
Trap 5: Memorizing Drugs Without Classes
Drug classes give you patterns for:
- Indications
- Adverse effects
- Interactions
- Naming
Learning 200 completely disconnected facts is far less efficient.
Trap 6: Avoiding Pharmacy Math
You cannot compensate for weak calculations simply by memorizing more drug names.
Trap 7: Assuming the 10 Unscored Questions Are at the End
They are mixed throughout the PTCE and are not identified.
Treat every question seriously.
PTCB Exam-Day Facts
How many questions are on the PTCB exam?
The PTCE contains 90 multiple-choice questions: 80 scored and 10 unscored.
How long is the PTCE?
Candidates receive 1 hour and 50 minutes for the exam, within a two-hour appointment that also includes the tutorial and survey.
What score do you need to pass?
The passing scaled score is 1,400 on a scale ranging from 1,000 to 1,600.
Frequently Asked Questions
Did the PTCB exam change in 2026?
Yes. The current PTCE Content Outline became effective January 6, 2026.
What is the biggest PTCB exam change?
One of the most important changes is the increased emphasis on Federal Requirements, which moved from 12.5% to 18.75% of exam content. DSCSA product serialization, tracking, tracing, handling, and quarantine requirements are also explicitly included in the current outline.
What percentage of the PTCB exam is medications?
Medications accounts for 35% of the current PTCE.
What percentage is pharmacy law?
The Federal Requirements domain represents 18.75% of the current exam.
Is pharmacy math still on the PTCB exam?
Yes. Calculations involving days supply, quantity, dose, concentration, dilution, ratios, proportions, and conversions are explicitly included.
Is DSCSA on the PTCB exam?
Yes. The current content outline explicitly includes FDA product serialization, tracking, tracing, handling, and quarantining requirements under the Drug Supply Chain Security Act.
Is nonsterile compounding still a major PTCE topic?
Procedures for compounding nonsterile products appeared as a dedicated knowledge area in the previous outline but do not appear as a dedicated knowledge area in the current 2026 outline.
Do I need to know all 200 drugs?
PTCB does not publish an official list titled “the Top 200 drugs.” The official blueprint instead requires knowledge of generic and brand names, classifications, indications, interactions, contraindications, side effects, dosing information, stability, and storage.
That is an important distinction: study commonly encountered drugs, but study them according to the skills PTCB actually specifies.
Key Takeaways
- The current PTCE blueprint became effective January 6, 2026.
- Medications now represents 35% of exam content.
- Federal Requirements increased to 18.75%.
- Patient Safety and Quality Assurance represents 23.75%.
- Order Entry and Processing represents 22.50%.
- DSCSA requirements are explicitly testable.
- Pharmacy calculations remain important.
- The exam contains 90 questions, including 10 unidentified unscored questions.
- The passing scaled score remains 1,400.
- Study medication classes and clinical safety patterns—not only brand/generic pairs.
- Know when pharmacist intervention is required.
- Make sure your study materials follow the current outline, because many older PTCB resources still teach the previous blueprint.
Test Your Knowledge Before Exam Day
Reading the updated blueprint tells you what can be tested.
Practice tells you whether you can actually apply it.
Use realistic PTCE-style questions to test yourself across all four current domains:
- Medications
- Federal Requirements
- Patient Safety and Quality Assurance
- Order Entry and Processing
Take our PTCB Practice Test to identify weak areas and make sure you’re preparing for the current PTCE—not the exam that existed before January 2026.
